Navigation Links
Rigel to Present at the 2008 Credit Suisse Healthcare Conference
Date:11/11/2008

SOUTH SAN FRANCISCO, Calif., Nov. 11 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, Rigel's president and chief executive officer, will present a company overview at the 2008 Credit Suisse Healthcare Conference on Thursday, November 13 at 4:30 p.m. MST. The conference will be held at the Arizona Biltmore Resort in Phoenix, Arizona.

To access the live audio webcast or the subsequent archived recording, log on to http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

Contact: Ryan Maynard

Phone: 650.624.1284

Email: invrel@rigel.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Rigel Announces Third Quarter 2008 Financial Results and Clinical Update
2. Rigel to Host Update Conference Call
3. Rigel Announces Fourth Quarter and Year End 2007 Financial Results
4. Rigel to Present at BIO CEO & Investor Conference
5. Rigel Announces Pricing of Public Offering of Common Stock
6. Rigel to Present Research Programs at Scientific Conferences
7. Rigel to Present at BIO Investor Forum 2007
8. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
9. Cynvec LLC(SM) to Present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 11, 2008
10. Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
11. Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at ASH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  Eli Lilly and Company (NYSE: ... galcanezumab for the prevention of migraine at the American ... place April 22-28, 2017, in Boston ... at AAN, including safety and patient outcomes data for ... a reduction in monthly migraine headache days among patients ...
(Date:4/20/2017)... (PRWEB) , ... April 20, 2017 , ... NetDimensions appoints ... Sales. , With over 20 years of experience in the learning technologies industry, Mastin ... sister company within Learning Technologies Group plc (LTG). At LEO, Mastin served as SVP ...
(Date:4/20/2017)... ... April 20, 2017 , ... Parallel6™ , the ... worldwide, announced today that they were named one of the 2017 Top 10 ... latest developments in the pharmaceutical industry. , “We take pride in honoring Parallel6 as ...
(Date:4/20/2017)... and PETACH TIKVAH, Israel , April ... leading developer of adult stem cell technologies for neurodegenerative diseases, ... will present at the Alliance for Regenerative Medicine,s (ARM) 5 ... Thursday, April 27, 2017 at 09:40 EDT in ... Kern , MD, MHSc, Chief Medical Officer & Chief Operating ...
Breaking Biology Technology:
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University ... adopting ground breaking 3D fingerprint minutiae recovery and matching technology, pushing ... for use in identification, crime investigation, immigration control, security of access ... ... A research team led by Dr Ajay ...
Breaking Biology News(10 mins):